For many, it began at Biogen event
Boston’s own superspreader covered the world, infecting 300,000 people
Last winter’s Biogen conference in Boston appears to have triggered a globetrotting COVID-19 superspreader that infected an estimated 300,000 people, a scientific study states.
The Feb. 26-27 meeting of managers held at the Boston Marriott Long Wharf hotel sent 100 attendees home with the coronavirus who then spread it to 29 states and other countries, the study posted in the journal Science reports.
In all, Biogen’s two-day brainstorming session is tied to an estimated 1.6% of all coronavirus infections in the U.S., the study states.
The report paints a chilling portrait of a contagion that raced out of Boston and across Massachusetts, never looking back. It also illustrates how ignorant even biotech leaders were of the novel coronavirus less than a year ago.
The scientific report is a whodunit of an invisible strain of SARS- CoV-2 that researchers said resulted in the virus spreading to Florida, North Carolina, Indiana, Australia, Sweden, Slovakia and beyond.
“Genome data reveal that the impact of the conference was far larger than the approximately 100 cases directly associated with the event,” the paper states.
“Using state-reported case counts, we estimate that by the end of the study period, approximately 50,000 diagnosed cases in the US resulted from conference-associated viruses; of these, 46% were in Massachusetts,” the report states. That included cases in Everett, Revere and Chelsea.
Here’s where the journal adds up the damage: “Through November 1, 2020, we estimate that a total of 245,000 cases marked by (one strain) and 88,000 cases marked by (another strain) were linked to the conference in the United States. While
Massachusetts accounted for most early spread related to the conference, Florida accounted for the greatest proportion of cases overall — 29.2%.”
Two genetic signatures tied to the managers’ meeting put on by the Cambridge-based Biogen provided researchers with “markers to track the onward spread of SARSCoV-2 from the event.”
The study was done to help understand the role of “superspreading events in transmission” for “prioritizing public health interventions,” the authors write.
The “cluster” of Biogen cases, the report adds, showed the “effect of this spread was long-lasting. By November 1, 2020, viruses containing (one cluster) could be found in 29 states.”
The researchers of this report — more than 50 named — include some from the Broad Institute of Harvard and MIT. The institute is helping Massachusetts research COVID19 to understand the nearly unstoppable contagious capacity of the virus. Harvard and most of Boston’s major hospitals are also represented in the bylines.
“Better understanding of transmission dynamics could contribute to more targeted and effective responses to the pandemic,” the authors write.
The Biogen conference sparked a rush of employees seeking testing at a nearby hospital days later and forced the Boston Marriott Long Wharf hotel to close soon after. The Biogen pool of those infected is now coveted data that was used in this Science report.
In April, Biogen announced it was helping in the research.
“We are uniquely positioned to contribute to advancing COVID-19 science in an organized and deliberate way so we can all gain a better understanding of this virus,” Biogen’s chief medical officer Dr. Maha Radhakrishnan said in a release announcing the project in April.
As of Friday, there have been 1.59 million deaths due to the virus worldwide and 70 million infections, according to the Johns Hopkins University virus tracker.